Esperion Therapeutics
ESPR
#8322
Rank
S$0.22 B
Marketcap
$1.16
Share price
-7.15%
Change (1 day)
-60.02%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): S$10.7 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.33 Billion. , an increase over its 2023 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 S$9.87 M-104.99%
2023 -S$0.2 Billion-15.03%
2022 -S$0.24 Billion-20.61%
2021 -S$0.3 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.27 Billion19.57%
2017 -S$0.23 Billion125.39%
2016 -S$98.12 Million51.43%
2015 -S$64.79 Million36.45%
2014 -S$47.49 Million43.55%
2013 -S$33.08 Million145.26%
2012 -S$13.49 Million
2002 -S$38.46 Million-7.81%
2001 -S$41.71 Million15.03%
2000 -S$36.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.67 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.71 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.61 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.28 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$37.82 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.27 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA